An epigenetic modifier triggers therapeutic immune responses against breast cancer
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1313376
Abstract: Lorenzo Galluzzi and Guido Kroemer Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Universit e Paris Descartes/Paris V, Sorbonne Paris Cit e, Paris, France; Universit e Pierre et Marie Curie/Paris VI,… read more here.
Keywords: modifier triggers; epigenetic modifier; paris france; cancer ... See more keywords